GlassScriptPhysician profile
Angela L Templeton
NPI 1528717386
$434.98
in general payments reported to CMS, 2019-2025
9 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.84 · 2023: $43.89 · 2024: $80.90 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $183.94 | 2025 | Iqirvo |
| Orphalan INC | $57.32 | 2024-2025 | Cuvrior |
| Gilead Sciences, INC. | $56.16 | 2025 | |
| Celgene Corporation | $28.94 | 2024 | Reblozyl |
| Abbvie INC. | $23.00 | 2025 | |
| Melinta Therapeutics, LLC | $22.14 | 2023 | Vabomere, Orbactiv, Kimyrsa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.89 | 2024 | Xifaxan |
| Alkermes, INC. | $21.75 | 2023 | Vivitrol |
| Paratek Pharmaceuticals, INC. | $19.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Templeton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.